Alchemia

About:

Alchemia Limited is a listed Australian biopharmaceutical company with an FDA approved drug and a late stage oncology product.

Website: http://www.alchemia.com.au/

Twitter/X: asxacl

Top Investors: BioScience Managers Limited

Description:

Alchemia Limited is a listed Australian biopharmaceutical company (ASX:ACL) with an FDA approved drug (Fondaparinux sodium) and a late stage oncology product pipeline derived from the HyACT platform. In addition, Alchemia has a drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise.

Total Funding Amount:

10.2M AUD

Headquarters Location:

Eight Mile Plains, Queensland, Australia

Founded Date:

1995-01-01

Contact Email:

enquiries(AT)alchemia.com.au

Founders:

Number of Employees:

1-10

Last Funding Date:

2013-03-11

IPO Status:

Public

Industries: